| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Baird analyst Amanda Sweitzer maintains Global Medical REIT (NYSE:GMRE) with a Neutral and lowers the price target from $45 ...
JMP Securities analyst Aaron Hecht upgrades Global Medical REIT (NYSE:GMRE) from Market Perform to Market Outperform and ann...
Global Medical REIT (NYSE:GMRE) affirms FY2025 FFO guidance from $0.89-$0.93 to $0.89-$0.93 vs $0.82 analyst estimate..
Global Medical REIT (NYSE:GMRE) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0....